Amendment of the Medicines for Human Use (Marketing Authorisations Etc.) Regulations 1994
regulation 3(a) of The Medicines (Provision of False or Misleading Information and Miscellaneous Amendments) Regulations 2005 (revoked)
- Status not determined
- Strict liability
- Drugs and medicines
This offence was read from the text as made, and no revised version was available, so a later revocation could not be ruled out. Check the current text at legislation.gov.uk.
What the provision says
a after paragraph
10 insert the following paragraph— 10A
1 Any person who in the course of an application for the grant, renewal or variation of
a marketing authorization for
a relevant medicinal product—
a fails to provide to the licensing authority any information which is relevant to an evaluation of the safety, quality or efficacy of the relevant medicinal product as required by point (7) or (11) of the introduction to Annex I to the 2001 Directive; or
b provides to the licensing authority any information which is relevant to an evaluation of the safety, quality or efficacy of the relevant medicinal product but which is false or misleading in
a material particular, shall be guilty of an offence.
Text as made, from legislation.gov.uk. © Crown copyright, reused under the Open Government Licence v3.0. This is the text as originally made; later amendments are not shown here.
Who it binds, and what has to be proved
- Binds
- a person
- Conduct
- making a false or misleading statement
- Fault element
- Strict liability
- Burden of proof
- No statutory defence — prosecution proves everything
The prosecution must prove that the conduct happened. This is a strict liability offence as drafted: the provision uses no word of intention, knowledge, recklessness or negligence, so there is no need to show that a person meant to do it, knew about it, or was careless.
Intention, knowledge and carelessness are irrelevant to guilt. They may still matter a great deal to sentence.
The provision states no defence, so the prosecution bears the burden on every element of the offence.
Classifier’s reasoning: no word of intention, knowledge, recklessness or negligence in the offence or its provision.
What would breach regulation 3(a)?
These are illustrations, not law. They are generated from the provision’s own words to show the shape of the offence. Whether any particular conduct is caught depends on the full text, on any amendment since, and on the facts.
- Entering a figure on a form or return that is known to be wrong under the Medicines (Provision of False or Misleading Information and Miscellaneous Amendments) Regulations 2005.
- Leaving out something the form asks for, where the omission is what makes the answer misleading.
- Producing a document to an official that has been altered since it was issued.
Penalty
- Mode of trial
- Not determined
- Maximum fine
- Not determined
- Maximum prison (summary)
- Not determined
no penalty is stated here: this instrument amends another one, and the penalty for the offence is in the instrument being amended.
No penalty was determined from this instrument. It may be in the enabling Act, or in a general penalties provision this pass did not connect to the offence. Absence of a figure here is not evidence that the offence carries no penalty.
Sentencing
Offences of this kind are usually sentenced under the guidelines below. This is a mapping by subject, not a finding about this provision, and the links go to a search of the Sentencing Council’s own site.
-
Drug offences: definitive guideline
Magistrates' courts and the Crown Court in England and Wales
Covers importation, supply, production and possession of controlled drugs, with sentencing driven by drug class and the offender's role.
-
Reduction in sentence for a guilty plea: definitive guideline
All courts in England and Wales · in force from 1 June 2017
The sliding scale of credit for pleading guilty, from one third at the first stage of proceedings downwards.
-
General guideline: overarching principles
All courts in England and Wales · in force from 1 October 2019
The guideline a court uses when there is no offence-specific guideline, which is the position for the overwhelming majority of offences created by statutory instrument. It sets out how culpability and harm are assessed from first principles.
-
Totality: definitive guideline
All courts in England and Wales
How to sentence more than one offence at once so that the total is just and proportionate - frequently in point here, because regulatory prosecutions commonly charge several breaches of the same instrument.
Prosecution figures
No published per-offence figure was found for this provision, and it could not be matched to a Ministry of Justice offence code. Offences created by statutory instrument very largely do not have one. Absence of a figure is not evidence that the offence is unused.
Status and lifecycle
- Current status
- Status not determined
- Made
- 24 June 2005
- In force from
- 1 August 2005
- Extent
- Not stated
How this was established: read from the text as made; no revised version available, so later revocation could not be ruled out.
What the instrument is for
(This note is not part of the Regulations) — the explanatory note published with the instrument, © Crown copyright.
These Regulations make amendments to: the Medicines (Standard Provisions for Licences and Certificates) Regulations 1971 (“the Standard Provisions Regulations”), which amongst other matters set the standard conditions for licences to manufacture or distribute by way of wholesale dealing medicinal products in the United Kingdom and which implement in part Titles IV and VII of Directive 2001/83/EC of the European Parliament and of the Council on the Community code relating to medicinal products for human use; and the Medicines for Human Use (Marketing Authorisations Etc.) Regulations 1994 (“the Marketing Authorisations Regulations”), which relate to the scheme for authorising the marketing of medicinal products for human use in the United Kingdom and which implement various provisions of Directive 2001/83/EC, as amended. Regulation 2 amends the Standard Provisions Regulations. A new requirement is imposed on holders of manufacturer’s licences to keep detailed records in relation to intermediate products used in the manufacture of biological medicinal products for human use. Holders of manufacturer’s and wholesale dealer’s licences are also required to take all reasonable precautions and exercise all due diligence to ensure that any information they provide to the licensing authority which is relevant to the evaluation of the safety, quality and efficacy of medicinal products for human use that they manufacture or deal in is not false or misleading in a material particular. Manufacturers are also required to take all reasonable precautions and exercise all due diligence to ensure that the information they provide about starting materials and intermediate products used in the manufacture of medicinal products for human use is not false or misleading in a material particular. Paragraphs (2) and (4)(a) correct minor errors arising from the Medicines (Codification Amendment Etc.) Regulations 2002, which updated the references in United Kingdom legislation to certain European Community instruments relating to medicinal products for human use to take account of the adoption of Directive 2001/83/EC. Regulation 3 amends the Marketing Authorisations Regulations. It creates new criminal offences for failures to provide information relevant to the evaluation of safety, quality or efficacy of a medicinal product for human use and for the provision of information to the licensing authority which is relevant to an evaluation of the safety, quality or efficacy of medicinal products for human use but which is false or misleading in a material particular. These offences relate to obligations under Directive 2001/83/EC; in particular the obligation on applicants for authorisation to provide all information relevant to an evaluation of a product’s safety, quality and efficacy (see Article 8 and the introduction to Annex I of Directive 2001/83/EC) and to keep this information up to date (Articles 23, 24 and 106(6)) and the obligation on competent authorities to evaluate products' safety, quality and efficacy both on receipt of an application for authorisation and during the currency of a marketing authorisation (see Articles 19, 21, 24, 26, 107 and 116). A Regulatory Impact Assessment in relation to these Regulations has been placed in the libraries of both Houses of Parliament, and copies can be obtained from the Medicines and Healthcare products Regulatory Agency, Market Towers, 1 Nine Elms Lane, London SW8 5NQ.
Read the full note and every offence in this instrument
Other offences in the same instrument
- In Schedule 3 of the Medicines for Human Use (Marketing Authorisations Etc.) Regulations 1994 (offences,…regulation 3
- Any person who— a is responsible for placing a relevant medicinal product on the market; b is the marketing…regulation 3(a)
- the following paragraph— 13A Any person who— a sells or supplies a relevant medicinal product in accordance…regulation 3(b)
How this was identified as an offence
Everything above rests on the judgement that this provision creates a criminal offence, rather than mentioning one. That judgement is made by rule, from the words of the provision, and this is the rule that made it — with a confidence of 0.92.
- Basis
- the provision says a person is “guilty of an offence”
- Confidence
- 0.92 of 1.00
A provision that states a penalty for an offence created elsewhere can read very like one that creates an offence, and the rules can mistake the one for the other. If the text quoted above sets a penalty for something made an offence by another provision, treat the classification on this page with that in mind, and read the instrument.
Check the source
- This provision on legislation.gov.uk The authoritative text. Check it before relying on anything here.
- The Medicines (Provision of False or Misleading Information and Miscellaneous Amendments) Regulations 2005 (revoked) Every offence this instrument creates, and its explanatory note
- Drugs and medicinesOther offences on the same subject
- Offences created in 2005